These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21673408)

  • 1. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.
    Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A
    J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
    Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H
    Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.
    Corbo RM; Gambina G; Ruggeri M; Scacchi R
    Dement Geriatr Cogn Disord; 2006; 22(1):67-72. PubMed ID: 16699281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis.
    Morón FJ; Mendoza N; Vázquez F; Molero E; Quereda F; Salinas A; Fontes J; Martínez-Astorquiza T; Sánchez-Borrego R; Ruiz A
    Bone; 2006 Jul; 39(1):213-21. PubMed ID: 16530497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.
    Ryan J; Carrière I; Carcaillon L; Dartigues JF; Auriacombe S; Rouaud O; Berr C; Ritchie K; Scarabin PY; Ancelin ML
    Alzheimers Dement; 2014 Jan; 10(1):27-35. PubMed ID: 23491264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies.
    Grünblatt E; Reif A; Jungwirth S; Galimberti D; Weber H; Scarpini E; Sauer C; Wichart I; Rainer MK; Huber K; Danielczyk W; Tragl KH; Deckert J; Fischer P; Riederer P
    J Psychiatr Res; 2011 Sep; 45(9):1250-6. PubMed ID: 21507424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias.
    Ban S; Sata F; Kurahashi N; Kasai S; Moriya K; Kakizaki H; Nonomura K; Kishi R
    Hum Reprod; 2008 Jun; 23(6):1466-71. PubMed ID: 18375409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females.
    Porrello E; Monti MC; Sinforiani E; Cairati M; Guaita A; Montomoli C; Govoni S; Racchi M
    Eur J Neurol; 2006 Jun; 13(6):639-44. PubMed ID: 16796589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
    Zubenko GS; Hughes HB; Stiffler JS
    Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.